Market Closed

INBX
Inhibrx Biosciences
$ 83.30
-5.07%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Inhibrx Biosciences News

Latest Inhibrx Biosciences Stock News & INBX Headlines

Inhibrx Reports Third Quarter 2026 Financial Results
2 days ago | prnewswire.com
Inhibrx Biosciences (NASDAQ:INBX) Shares Cross Below 200-Day Moving Average – Here’s What Happened
20 days ago | defenseworld.net
Inhibrx Announces Participation in Upcoming Scientific Conferences
a month ago | prnewswire.com
Inhibrx's Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
a month ago | marketbeat.com
Inhibrx Biosciences (NASDAQ:INBX) Shares Climb 3.7% on Insider Buying Activity
2 months ago | defenseworld.net
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Up 3.7% Following Insider Buying Activity
2 months ago | defenseworld.net
Inhibrx Biosciences (NASDAQ:INBX) Stock: Insider Jon Faiz Kayyem Buys 5,000 Shares
2 months ago | defenseworld.net
Insider Buying: Inhibrx Biosciences (NASDAQ:INBX) Director Purchases $500,000.00 in Stock
2 months ago | defenseworld.net
Inhibrx Founder and CEO Mark Lappe Buys 25,000 Shares for $2.6 Million. What Does His Confidence Tell Investors?
2 months ago | fool.com
Inhibrx: 'Strong Buy' Maintained With Ozekibart Action Date On The Horizon And Study Win With INBRX-106
2 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

INBX
Inhibrx Biosciences
$ 83.30
-5.07%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago